Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond

SIMPLE SUMMARY: In the latest WHO classification, solitary fibrous tumors (SFTs) are now subdivided into benign SFT (intermediate category (locally aggressive)), SFT NOS (intermediate category (rarely metastasizing)), and malignant SFT. Thanks to recent progress in molecular characterization, the id...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bernardi, Axel, Dufresne, Armelle, Mishellany, Florence, Blay, Jean-Yves, Ray-Coquard, Isabelle, Brahmi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870479/
https://www.ncbi.nlm.nih.gov/pubmed/35205812
http://dx.doi.org/10.3390/cancers14041064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870479/
https://www.ncbi.nlm.nih.gov/pubmed/35205812
http://dx.doi.org/10.3390/cancers14041064

Ejemplares similares